Objective: The use of procalcitonin (ProCT) as a marker of several clinical conditions, in
particular, systemic inflammation, infection, and sepsis, will be clarified, and its current …

Induction of the protein procalcitonin during infection and inflammation was first described
approximately 10 years ago. A large number of publications, primarily clinical studies …

The first symptoms of malaria, common to all the different malaria species, are nonspecific
and mimic a flu-like syndrome. Although fever represents the cardinal feature, clinical …

Since December 2019, a novel coronavirus (severe acute respiratory syndrome—
coronavirus 2, SARS-CoV-2) has rapidly spread around the world resulting in an acute …

Prompt diagnosis and treatment with appropriate antimicrobial chemotherapy is of
paramount importance to reduce morbidity and mortality associated with sepsis …

The continuous increase in long-distance travel and recent large migratory movements have
changed the epidemiological characteristics of imported malaria in countries where malaria …

We prospectively evaluated serum procalcitonin concentrations in patients who presented to
an emergency department (ED) with suspected infectious or inflammatory disease. Of 195 …

Background Severe malaria is a leading cause of childhood mortality in Africa. However, at
presentation, it is difficult to predict which children with severe malaria are at greatest risk of …

Recent data and cumulative analyses indicate that biomarkers of sepsis improve diagnosis
of sepsis. However, only a few markers have impact on therapy and fulfill the clinical …

The clinical significance of serum procalcitonin (PCT) for discriminating between bacterial
infectious disease and nonbacterial infectious disease (such as systemic inflammatory …